U-Blot® Research Grade Idarucizumab
Product details
Background:Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis.
• Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial., PMID:33290737
• Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism., PMID:35699915
• The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market., PMID:37044200
• Dose tailoring of dabigatran etexilate: obvious or excessive?, PMID:25994994
• A Pharmacokinetic Evaluation of Dabigatran Etexilate, Total Dabigatran, and Unconjugated Dabigatran Following the Administration of Dabigatran Etexilate Mesylate Capsules in Healthy Male and Female Subjects., PMID:31652461
• Idarucizumab for Dabigatran Reversal – Full Cohort Analysis., PMID:28693366
• Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation., PMID:28185082
• Direct oral anticoagulants: evidence and unresolved issues., PMID:33248499
• Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta., PMID:24807346
• The discovery of dabigatran etexilate for the treatment of venous thrombosis., PMID:27159158
Specifications
| Target | Dabigatran Etexilate Mesylate |
| Reactivity | General |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| MW(Calculated) | |
| MW(Observed) | |
| Host Species | Humanized |
| Isotype | Fab-G1-kappa |
| Conjugate/Modification | |
| Modification | |
| Recommended Dilution Ratio | |
| Composition | 0.01M PBS, pH 7.4. |
| Purification Process | Protein A/G purified from cell culture supernatant. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Storage Condition | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Concentration | |
| Clonality | Monoclonal |
| Clone Number | |
| Immunogen | Mammalian Cells |
| Gene Name | |
| Protein Name | |
| Alias | Dabigatran Etexilate Mesylate |
| Species | |
| Gene ID-1 | 211915-06-9 |
| Uniprot | |
| Species.1 | |
| Gene ID | |
| Uniprot.1 | |
| Species.2 | |
| Gene ID.1 | |
| Uniprot.2 | |
| Organism-4 | |
| Gene ID-4 | |
| SwissProt-4 | |
| Description | Background:Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis.<br>• Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial., PMID:33290737<br />• Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism., PMID:35699915<br />• The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market., PMID:37044200<br />• Dose tailoring of dabigatran etexilate: obvious or excessive?, PMID:25994994<br />• A Pharmacokinetic Evaluation of Dabigatran Etexilate, Total Dabigatran, and Unconjugated Dabigatran Following the Administration of Dabigatran Etexilate Mesylate Capsules in Healthy Male and Female Subjects., PMID:31652461<br />• Idarucizumab for Dabigatran Reversal - Full Cohort Analysis., PMID:28693366<br />• Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation., PMID:28185082<br />• Direct oral anticoagulants: evidence and unresolved issues., PMID:33248499<br />• Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta., PMID:24807346<br />• The discovery of dabigatran etexilate for the treatment of venous thrombosis., PMID:27159158<br /> |
| Cellular Localization | |
| Tissue Expression | |
| Signaling_pathway | |
| Research Areas | |
| Function |






